# Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

> **NCT06880848** · PHASE4 · COMPLETED · sponsor: **Jemincare** · enrollment: 160 (actual)

## Conditions studied

- Carcinoma, Basal Cell (BCC)

## Interventions

- **DRUG:** Sonidegib Phosphate Capsules

## Key facts

- **NCT ID:** NCT06880848
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-21
- **Primary completion:** 2025-08-26
- **Final completion:** 2025-08-26
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06880848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06880848, "Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06880848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*